Sign in

CIK 0001662774 · Non-accelerated filer<br>Smaller reporting company

IRulya Therapeutics Inc.

Sign in to watch
Ticker
IRLA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
901024039
Phone
203-208-8994
Business address
101 COLLEGE STREET, SUITE 210, NEW HAVEN, CT, 06510
Former names
Quince Therapeutics, Inc., Cortexyme, Inc.
  1. DEF 14A Proxy Proxy Statement
  2. PRE 14A Proxy Proxy Statement (Preliminary)
  3. S-8 Other Securities Offered to Employees in Benefit Plans
  4. 10-K Report Annual Report
  5. 4 Insider Changes in Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 8-K Event Executive or director change
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 8-K Event Executive or director change
  15. 4 Insider Changes in Ownership
  16. 8-K/A Event Exhibits
  17. 8-K Event Other events
  18. 8-K Event Agreement ended
  19. SC 13G Stake Amended Statement of Ownership
  20. 4 Insider Changes in Ownership

Page 9 of 24 · 467 filings